Documents
Application Sponsors
ANDA 205397 | PERRIGO ISRAEL | |
Marketing Status
Application Products
001 | GEL;TOPICAL | 2.5%;EQ 1.2% BASE | 0 | CLINDAMYCIN PHOSPHATE AND BENZOYL PEROXIDE | BENZOYL PEROXIDE; CLINDAMYCIN PHOSPHATE |
FDA Submissions
UNKNOWN; | ORIG | 1 | AP | 2019-09-09 | STANDARD |
Submissions Property Types
TE Codes
CDER Filings
PERRIGO ISRAEL
cder:Array
(
[0] => Array
(
[ApplNo] => 205397
[companyName] => PERRIGO ISRAEL
[docInserts] => ["",""]
[products] => [{"drugName":"CLINDAMYCIN PHOSPHATE AND BENZOYL PEROXIDE","activeIngredients":"BENZOYL PEROXIDE; CLINDAMYCIN PHOSPHATE","strength":"2.5%;EQ 1.2% BASE","dosageForm":"GEL;TOPICAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
[labels] =>
[originalApprovals] => [{"actionDate":"09\/09\/2019","submission":"ORIG-1","actionType":"Approval","submissionClassification":"","reviewPriority":"STANDARD","inserts":"[{\"name\":\"Letter (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/appletter\\\/2017\\\/205397Orig1s000TAltr.pdf\"}]","notes":"> Label is not available on this site."}]
[supplements] =>
[actionDate] => 2019-09-09
)
)